Noveris Health Sciences is trading at CA$0.07, up 7.69%; broader-market gains offer a possible backdrop, but no direct link is confirmed. - The S&P 500 was up 0.53% and Nasdaq Composite 1.08%. - No company-specific announcement dated October 19 or October 16 appears on Noveris Health Sciences’ release page; its latest listed release is September 9. - Canadian biotech stocks were down 8.4% over the prior seven days; trading volume or activity details were unavailable in the sources reviewed.